All Things Biosimilar

Business EN ↓ Odcinki: 4

Stay on the pulse of the U.S. biosimilars industry with All Things Biosimilar. Hosted by Andrew Bourgoin, founder of Bourgoin Insights Group, this podcast is your source for timely insights into the dynamic biosimilar market. Each episode unpacks the latest developments, including in-depth analysis of the U.S. retina market, the competitive dynamics for ustekinumab and aflibercept biosimilars, and what to watch for in quarterly earnings. If you need to understand the forces driving the market today, this is the podcast for you. Subscribe to stay informed.

Autor

All Things Biosimilar

Kategoria

Business

Ostatni odcinek

25 lis 2025

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Zainstaluj za darmo Android 5 mln+ pobrań · ocena 4,8 iOS niedługo

Odcinki

All Things Biosimilar - Episode 3 25.11.2025 31:40

Welcome to All Things Biosimilar Podcast Join Andrew Bourgoin, founder of Bourgoin Insights Group, as he introduces the All Things Biosimilar Podcast, an insightful series dedicated to the US biosimilars market. With over 15 years of industry experience, Andrew discusses various topics related to the market. Subscribe now to stay informed about the evolving U.S. biosimilars landscape. In Episode T...

All Things Biosmilar - Introduction 15.10.2025 4:33

Welcome to All Things Biosimilar Podcast Join Andrew Bourgoin, founder of Bourgoin Insights Group, as he introduces the All Things Biosimilar Podcast, an insightful series dedicated to the US biosimilars market. With over 15 years of industry experience, Andrew discusses the podcast's goal to deliver comprehensive analysis, timely market insights, and monitoring services. Learn about the 351K...

All Things Biosimilar - Episode 1 15.10.2025 12:31

Welcome to All Things Biosimilar Podcas t Join Andrew Bourgoin, founder of Bourgoin Insights Group, as he introduces the All Things Biosimilar Podcast, an insightful series dedicated to the US biosimilars market. With over 15 years of industry experience, Andrew discusses various topics related to the market. Subscribe now to stay informed about the evolving U.S. biosimilars landscape. In Episode...

All Things Biosimilar - Episode 2 15.10.2025 53:37